Sep 12, 2022
Therapeutic intended to restore lost vision in patients with Retinitis Pigmentosa (RP) granted approval to start a Phase 1b trial.
Aug 24, 2022
Oxford-Harrington Rare Disease Centre is working to advance scientific research and drug development to make curing rare diseases a reality.
Aug 22, 2022
Learn more about Harrington Discovery Institute’s recent success in fulfilling its mission to accelerate promising discoveries into medicines for unmet needs.
Aug 02, 2022
Oxford-Harrington Rare Disease Centre announce support for novel treatment for Duchenne muscular dystrophy, a rare neuromuscular disease characterized by progressive muscle degeneration and weakness.
Mar 31, 2022
Developing cures for rare and ultra-rare diseases has its challenges, but patients like Cooper New provide inspiration to discover new treatments.
Jun 04, 2019
Morgan Stanley GIFT CuresSM is a philanthropic collaboration with Harrington Discovery Institute.
Feb 28, 2019
Joint program combines capabilities to improve treatment options globally for patients with rare diseases.
Dec 10, 2018
More than 100 drug discovery projects now supported by Harrington Discovery Institute.
Jan 01, 2018
Read Harrington Discovery Institute's 2017 annual report highlighting the past five years of discovery and medical innovation.